Literature DB >> 28161409

Gain-of-function STAT1 mutations are associated with intracranial aneurysms.

Mete Dadak1, Roland Jacobs2, Jelena Skuljec3, Adan Chari Jirmo3, Özlem Yildiz4, Frank Donnerstag1, Niklas Thomas Baerlecken2, Reinhold Ernst Schmidt2, Heinrich Lanfermann1, Thomas Skripuletz4, Philipp Schwenkenbecher4, Christoph Kleinschnitz5, Hayrettin Tumani6, Martin Stangel4, Refik Pul7.   

Abstract

Chronic mucocutaneous candidiasis, characterized by persistent or recurrent fungal infections, represents the clinical hallmark in gain-of-function (GOF) signal transducer and activator of transcription 1 (STAT1) mutation carriers. Several cases of intracranial aneurysms have been reported in patients with GOF STAT1 mutation but the paucity of reported cases likely suggested this association still as serendipity. In order to endorse this association, we link the development of intracranial aneurysms with STAT1 GOF mutation by presenting the two different cases of a patient and her mother, and demonstrate upregulated phosphorylated STAT4 and IL-12 receptor β1 upon stimulation in patient's blood cells. We also detected increased transforming growth factor (TGF)-β type 2 receptor expression, particularly in CD14+ cells, and a slightly higher phosphorylation rate of SMAD3. In addition, the mother of the patient developed disseminated bacille Calmette-Guérin disease after vaccination, speculating that GOF STAT1 mutations may confer a predisposition to weakly virulent mycobacteria.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aneurysm; Chronic mucocutaneous candidiasis; Gain-of-function mutation; Mendelian susceptibility to mycobacterial disease; SMAD3; STAT1; STAT4; Transforming growth factor-β

Mesh:

Substances:

Year:  2017        PMID: 28161409     DOI: 10.1016/j.clim.2017.01.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  6 in total

1.  Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors.

Authors:  Emilie W Borgström; Marie Edvinsson; Lucía P Pérez; Anna C Norlin; Sara L Enoksson; Susanne Hansen; Anders Fasth; Vanda Friman; Olle Kämpe; Robert Månsson; Hernando Y Estupiñán; Qing Wang; Tan Ziyang; Tadepally Lakshmikanth; Carl Inge E Smith; Petter Brodin; Peter Bergman
Journal:  J Clin Immunol       Date:  2022-09-02       Impact factor: 8.542

Review 2.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

Review 3.  Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017.

Authors:  Cristiane de Jesus Nunes-Santos; Sergio D Rosenzweig
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

Review 4.  Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

Authors:  Riccardo Castagnoli; Ottavia Maria Delmonte; Enrica Calzoni; Luigi Daniele Notarangelo
Journal:  Front Pediatr       Date:  2019-08-08       Impact factor: 3.418

5.  Gain-of-function STAT1 mutation and visceral leishmaniasis.

Authors:  Paula Teixeira Lyra; Ana Carla Augusto Moura Falcão; Rafael Amora Cruz; Antonio Victor Campos Coelho; Edvaldo da Silva Souza; Luiz Claudio Arraes de Alencar; João Bosco Oliveira
Journal:  Einstein (Sao Paulo)       Date:  2022-09-12

Review 6.  Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy.

Authors:  Linda Davidson; Mihai G Netea; Bart Jan Kullberg
Journal:  J Fungi (Basel)       Date:  2018-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.